Breaking News

Novavax, Inc.

Louis Fries III, M.D., has been appointed vice president, clinical and medical affairs, and Jane Halpern, Ph.D., has been appointed vice president of regulatory affairs at Novavax, Inc.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Louis Fries III, M.D., has been appointed vice president, clinical and medical affairs, and Jane Halpern, Ph.D., has been appointed vice president of regulatory affairs at Novavax, Inc. Prior to joining the company, Dr. Fries was director of global clinical development at GSK Biologicals, North America. Previously, he was vice president, clinical and medical affairs at ID Biomedical Corp. (acquired by GSK in 2005) and senior director of clinical research at NABI. Dr. Halpern previously se...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters